Don’t Eat the Yellow Rice: The Danger of Deploying Vitamin A Golden Rice
By Ted Greiner,
Independent Science News
| 07. 11. 2016
What better way to discredit your critics than to rope in 107 naive Nobel Prize winners (all without relevant expertise) to criticize your opposition?
But such tactics are not new. Long ago, the GMO industry spent well over $50 million to promote “Golden Rice” as the solution to vitamin A deficiency in low income countries. They did so well before the technology was completely worked out, let alone tested. Let alone consumer acceptability tested. Let alone subjecting it to standard phase 2 and 3 trials to see if it could ever solve problems in the real world.
So why has this apparently straightforward scientific project not reached completion after so many decades?
Because the purpose of Golden Rice was never to solve vitamin A problems. It never could and never will. It’s purpose from the beginning was to be a tool for use in shaming GMO critics and now to convince Nobel Laureates to sign on to something they didn’t understand.
I worked with a conventional fortified rice technology (Ultra Rice) for years for the NGO PATH in...
Related Articles
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Tory Shepherd, The Guardian | 06.13.2025
IVF is “big business” and experts are concerned about conflicts of interest between profit-making and helping families have children.
Monash IVF’s second embryo bungle has sparked renewed scrutiny on the IVF industry as a whole amid calls for national regulation...
By Hilary Bowman-Smart and Craig Stanbury, The Conversation | 06.12.2025